L. Gan, J. Wang, M. Jiang, H. Bartlett, D. Ouyang et al., Recent advances in topical ophthalmic drug delivery with lipid-based nanocarriers, Drug Discovery Today, vol.18, issue.5-6, pp.290-297, 2013.
DOI : 10.1016/j.drudis.2012.10.005

L. Bourlais, C. Acar, L. Zia, H. Sado, P. A. Needham et al., Ophthalmic drug delivery systems???Recent advances, Progress in Retinal and Eye Research, vol.17, issue.1, pp.33-58, 1998.
DOI : 10.1016/S1350-9462(97)00002-5

D. Achouri, K. Alhanout, and P. Piccerelle, Recent advances in ocular drug delivery, Drug Development and Industrial Pharmacy, vol.2, issue.11, pp.1599-1617, 2013.
DOI : 10.1007/978-0-387-74904-4_5

V. K. Yellepeddi and S. Palakurthi, Recent Advances in Topical Ocular Drug Delivery, Journal of Ocular Pharmacology and Therapeutics, vol.32, issue.2, pp.67-82, 2016.
DOI : 10.1089/jop.2015.0047

R. S. Kalhapure, N. Suleman, C. Mocktar, N. Seedat, and T. Govender, Nanoengineered Drug Delivery Systems for Enhancing Antibiotic Therapy, Journal of Pharmaceutical Sciences, vol.104, issue.3, pp.872-905, 2015.
DOI : 10.1002/jps.24298

S. Sharma, Antibiotic resistance in ocular bacterial pathogens, Indian Journal of Medical Microbiology, vol.29, issue.3, pp.218-222, 2011.
DOI : 10.4103/0255-0857.83903

L. A. Remington, Clinical anatomy and physiology of the visual system, 2012.

M. J. Rathbone, J. Hadgraft, M. S. Roberts, and M. E. Lane, Modified-release drug delivery technology (Drugs and the pharmaceutical sciences, 2008.

M. Goel, R. G. Picciani, R. K. Lee, and S. K. Bhattacharya, Aqueous Humor Dynamics: A Review~!2010-03-03~!2010-06-17~!2010-09-02~!, The Open Ophthalmology Journal, vol.4, issue.1, pp.52-59, 2010.
DOI : 10.2174/1874364101004010052
URL : http://benthamopen.com/contents/pdf/TOOPHTJ/TOOPHTJ-4-52.pdf

K. Cholkar, S. R. Dasari, D. Pal, and A. K. Mitra, Eye: anatomy, physiology and barriers to drug delivery, In Ocular Transporters, pp.1-36, 2013.
DOI : 10.1533/9781908818317.1

M. L. Occhiutto, F. R. Freitas, R. C. Maranhao, and V. P. Costa, Breakdown of the Blood-Ocular Barrier as a Strategy for the Systemic Use of Nanosystems, Pharmaceutics, vol.21, issue.2, pp.252-275, 2012.
DOI : 10.1016/j.drudis.2007.11.002

J. Cunha-vaz, The blood-ocular barriers, Survey of Ophthalmology, vol.23, issue.5, pp.279-296, 1979.
DOI : 10.1016/0039-6257(79)90158-9

M. Chen, P. Hou, T. Tai, and B. J. Lin, Blood-Ocular Barriers, Tzu Chi Medical Journal, vol.20, issue.1, pp.25-34, 2008.
DOI : 10.1016/S1016-3190(08)60004-X
URL : https://doi.org/10.1016/s1016-3190(08)60004-x

R. Gaudana, H. K. Ananthula, A. Parenky, and A. K. Mitra, Ocular Drug Delivery, The AAPS Journal, vol.12, issue.3, pp.348-360, 2010.
DOI : 10.1208/s12248-010-9183-3

A. Patel, Ocular drug delivery systems: An overview, World Journal of Pharmacology, vol.2, issue.2, p.47
DOI : 10.1007/s11095-010-0271-y
URL : https://doi.org/10.5497/wjp.v2.i2.47

P. J. Pisella, K. Fillacier, P. P. Elena, C. Debbasch, and C. Baudouin, Comparison of the Effects of Preserved and Unpreserved Formulations of Timolol on the Ocular Surface of Albino Rabbits, Ophthalmic Research, vol.32, issue.1, pp.3-8, 2000.
DOI : 10.1159/000055579

P. Van-der-bijl, A. D. Van-eyk, and D. Meyer, Effects of Three Penetration Enhancers on Transcorneal Permeation of Cyclosporine, Cornea, vol.20, issue.5, pp.505-508, 2001.
DOI : 10.1097/00003226-200107000-00013

J. D. Bartlett and S. D. Jaanus, Clinical ocular pharmacology, 1989.

Y. Bakkour, G. Vermeersch, M. Morcellet, F. Boschin, and B. Martel, Formation of Cyclodextrin Inclusion Complexes with Doxycyclin-Hyclate: NMR Investigation of Their Characterisation and Stability, Journal of Inclusion Phenomena and Macrocyclic Chemistry, vol.338, issue.1-2, pp.109-114, 2006.
DOI : 10.1002/recl.19560750711

H. H. Sigurdsson, E. Stefánsson, E. Gudmundsdóttir, T. Eysteinsson, M. Thorsteinsdóttir et al., Cyclodextrin formulation of dorzolamide and its distribution in the eye after topical administration, Journal of Controlled Release, vol.102, issue.1, pp.255-262, 2005.
DOI : 10.1016/j.jconrel.2004.10.004

T. Loftsson and T. Järvinen, Cyclodextrins in ophthalmic drug delivery, Advanced Drug Delivery Reviews, vol.36, issue.1, pp.59-79, 1999.
DOI : 10.1016/S0169-409X(98)00055-6

M. Al-ghabeish, X. Xu, Y. S. Krishnaiah, Z. Rahman, Y. Yang et al., Influence of drug loading and type of ointment base on the in vitro performance of acyclovir ophthalmic ointment, International Journal of Pharmaceutics, vol.495, issue.2, pp.783-791, 2015.
DOI : 10.1016/j.ijpharm.2015.08.096

S. Kirchhof, A. M. Goepferich, and F. P. Brandl, Hydrogels in ophthalmic applications, European Journal of Pharmaceutics and Biopharmaceutics, vol.95, pp.227-238, 2015.
DOI : 10.1016/j.ejpb.2015.05.016

A. Khare, K. Grover, P. Pawar, and I. Singh, Mucoadhesive Polymers for Enhancing Retention in Ocular Drug Delivery: A Critical Review, Reviews of Adhesion and Adhesives, vol.2, issue.4, pp.467-502, 2014.
DOI : 10.7569/RAA.2014.097310

S. Roy, K. Pal, A. Anis, K. Pramanik, and B. Prabhakar, Polymers in Mucoadhesive Drug-Delivery Systems: A Brief Note, Designed Monomers and Polymers, vol.92, issue.6, pp.483-495, 2009.
DOI : 10.1093/jac/dkh411
URL : http://www.tandfonline.com/doi/pdf/10.1163/138577209X12478283327236?needAccess=true

M. Bora, R. C. Mundargi, Y. Chee, T. T. Wong, and S. S. Venkatraman, 5-Flurouracil microencapsulation and impregnation in hyaluronic acid hydrogel as composite drug delivery system for ocular fibrosis, Cogent Medicine, vol.16, issue.3
DOI : 10.1016/0169-409X(95)00017-2
URL : https://doi.org/10.1080/2331205x.2016.1182108

J. Lai, D. H. Ma, H. Cheng, C. Sun, S. Huang et al., Ocular Biocompatibility of Carbodiimide Cross-Linked Hyaluronic Acid Hydrogels for Cell Sheet Delivery Carriers, Journal of Biomaterials Science, Polymer Edition, vol.28, issue.3, pp.359-376, 2010.
DOI : 10.1016/j.biomaterials.2006.12.010

L. K. Widjaja, M. Bora, P. N. Chan, V. Lipik, T. T. Wong et al., Hyaluronic acid-based nanocomposite hydrogels for ocular drug delivery applications, Journal of Biomedical Materials Research Part A, vol.104, issue.9, pp.3056-3065, 2014.
DOI : 10.1016/0003-2697(80)90269-9

G. Rajoria and A. Gupta, In situ Gelling System: A novel approach for ocular drug delivery, Am. J. PharmTech Res, vol.2012, issue.2, pp.25-53

Y. Cao, C. Zhang, W. Shen, Z. Cheng, L. Yu et al., Poly(N-isopropylacrylamide)???chitosan as thermosensitive in situ gel-forming system for ocular drug delivery, Journal of Controlled Release, vol.120, issue.3, pp.186-194, 2007.
DOI : 10.1016/j.jconrel.2007.05.009

A. Khateb, K. Ozhmukhametova, E. K. Mussin, M. N. Seilkhanov, S. K. Rakhypbekov et al., In situ gelling systems based on Pluronic F127/Pluronic F68 formulations for ocular drug delivery, International Journal of Pharmaceutics, vol.502, issue.1-2, pp.70-79, 2016.
DOI : 10.1016/j.ijpharm.2016.02.027

H. Almeida, M. H. Amaral, P. Lobão, and J. M. Lobo, In situ gelling systems: a strategy to improve the bioavailability of ophthalmic pharmaceutical formulations, Drug Discovery Today, vol.19, issue.4, pp.400-412
DOI : 10.1016/j.drudis.2013.10.001

K. Mane and S. Dhole, In situ gelling system -A novel approach for ocular drug delivery, World J. Pharm. Pharm. Sci, vol.2014, issue.3, pp.317-333

I. D. Gonjari, A. B. Karmarkar, T. S. Khade, A. H. Hosmani, and R. B. Navale, Use of factorial design in formulation and evaluation of ophthalmic gels of gatifloxacin: Comparison of different mucoadhesive polymers, Drug Discov. Ther, vol.4, pp.423-434, 2010.

B. Buchan, G. Kay, A. Heneghan, K. H. Matthews, and D. Cairns, Gel formulations for treatment of the ophthalmic complications in cystinosis, International Journal of Pharmaceutics, vol.392, issue.1-2, pp.192-197, 2010.
DOI : 10.1016/j.ijpharm.2010.03.065

N. A. Peppas, P. Bures, W. Leobandung, and H. Ichikawa, Hydrogels in pharmaceutical formulations, European Journal of Pharmaceutics and Biopharmaceutics, vol.50, issue.1, pp.27-46, 2000.
DOI : 10.1016/S0939-6411(00)00090-4

B. Jeong, S. W. Kim, and Y. Bae, Thermosensitive sol???gel reversible hydrogels, Advanced Drug Delivery Reviews, vol.54, issue.1, pp.37-51, 2002.
DOI : 10.1016/S0169-409X(01)00242-3

, Pharmaceutics, vol.10, pp.10-25, 2018.

H. Almeida, M. H. Amaral, P. Lobão, and J. M. Sousa-lobo, Applications of poloxamers in ophthalmic pharmaceutical formulations: an overview, Expert Opinion on Drug Delivery, vol.4, issue.8, pp.1223-1237, 2013.
DOI : 10.3109/1061186X.2012.723214

Z. He, Z. Wang, H. Zhang, X. Pan, W. Su et al., Doxycycline and hydroxypropyl-??-cyclodextrin complex in poloxamer thermal sensitive hydrogel for ophthalmic delivery, Acta Pharmaceutica Sinica B, vol.1, issue.4, pp.254-260, 2011.
DOI : 10.1016/j.apsb.2011.10.004

K. Cho, Release of ciprofloxacin from poloxamer-graft-hyaluronic acid hydrogels in vitro, International Journal of Pharmaceutics, vol.260, issue.1, pp.83-91, 2003.
DOI : 10.1016/S0378-5173(03)00259-X

L. Mayol, F. Quaglia, A. Borzacchiello, L. Ambrosio, and M. Rotonda, A novel poloxamers/hyaluronic acid in situ forming hydrogel for drug delivery: Rheological, mucoadhesive and in vitro release properties, European Journal of Pharmaceutics and Biopharmaceutics, vol.70, issue.1, pp.199-206, 2008.
DOI : 10.1016/j.ejpb.2008.04.025

D. H. Shastri, S. T. Prajapati, and L. Patel, Studies on poloxamer based mucoadhesive insitu ophthalmic hydrogel of moxifloxacin HCL, Curr. Drug Deliv, vol.3, pp.238-243, 2010.

T. Gratieri, G. M. Gelfuso, E. M. Rocha, V. H. Sarmento, O. De-freitas et al., A poloxamer/chitosan in situ forming gel with prolonged retention time for ocular delivery, European Journal of Pharmaceutics and Biopharmaceutics, vol.75, issue.2, pp.186-193, 2010.
DOI : 10.1016/j.ejpb.2010.02.011

B. Srividya, R. M. Cardoza, and P. Amin, Sustained ophthalmic delivery of ofloxacin from a pH triggered in situ gelling system, Journal of Controlled Release, vol.73, issue.2-3, pp.205-211, 2001.
DOI : 10.1016/S0168-3659(01)00279-6

S. Patil, A. Kadam, S. Bandgar, and S. Patil, Formulation and evaluation of an in situ gel for ocular drug delivery of anticonjunctival drug, Cellulose Chem. Technol, vol.49, pp.35-40, 2015.

S. B. Makwana, V. A. Patel, and S. J. Parmar, Development and characterization of in situ gel for ophthalmic formulation containing ciprofloxacin hydrochloride. Results Pharma Sci, pp.1-6, 2016.

S. Mandal, G. Prabhushankar, M. Thimmasetty, and M. Geetha, Formulation and evaluation of an in situ gel-forming ophthalmic formulation of moxifloxacin hydrochloride, International Journal of Pharmaceutical Investigation, vol.2, issue.2, p.78, 2012.
DOI : 10.4103/2230-973X.100042

J. Carlfors, K. Edsman, R. Petersson, and K. Jörnving, Rheological evaluation of Gelrite?? in situ gels for ophthalmic use, European Journal of Pharmaceutical Sciences, vol.6, issue.2, pp.113-119, 1998.
DOI : 10.1016/S0928-0987(97)00074-2

Y. Sultana, M. Aqil, and A. Ali, Ion-Activated, Gelrite??-Based in Situ Ophthalmic Gels of Pefloxacin Mesylate: Comparison with Conventional Eye Drops, Drug Delivery, vol.23, issue.6, pp.215-219, 2006.
DOI : 10.1128/AAC.28.4.581

A. Joshi, S. Ding, and K. Himmelstein, J. Reversible Gelation Compositions and Methods of Use. U.S, p.15, 1990.

Y. Liu, J. Liu, X. Zhang, R. Zhang, Y. Huang et al., In Situ Gelling Gelrite/Alginate Formulations as Vehicles for Ophthalmic Drug Delivery, AAPS PharmSciTech, vol.11, issue.2, pp.610-620, 2010.
DOI : 10.1208/s12249-010-9413-0

M. Fanun, Microemulsions as delivery systems, Current Opinion in Colloid & Interface Science, vol.17, issue.5, pp.306-313
DOI : 10.1016/j.cocis.2012.06.001

P. K. Ghosh and R. S. Murthy, Microemulsions: A Potential Drug Delivery System, Current Drug Delivery, vol.3, issue.2, pp.167-180, 2006.
DOI : 10.2174/156720106776359168

T. F. Vandamme, Microemulsions as ocular drug delivery systems: recent developments and future challenges, Progress in Retinal and Eye Research, vol.21, issue.1, pp.15-34, 2002.
DOI : 10.1016/S1350-9462(01)00017-9

S. Tamilvanan and S. Benita, The potential of lipid emulsion for ocular delivery of lipophilic drugs, European Journal of Pharmaceutics and Biopharmaceutics, vol.58, issue.2, pp.357-368, 2004.
DOI : 10.1016/j.ejpb.2004.03.033

F. Lallemand, P. Daull, S. Benita, R. Buggage, and J. Garrigue, Successfully Improving Ocular Drug Delivery Using the Cationic Nanoemulsion, Novasorb, Journal of Drug Delivery, vol.52, issue.3821, p.604204, 2012.
DOI : 10.1016/S0021-5155(97)00128-7

A. Van, Eye irritation: studies relating to responses in man and laboratory animals, J. Soc. Cosmet. Chem. Jpn, vol.24, pp.685-692, 1973.

J. Yin, C. Xiang, and G. Lu, Cationic lipid emulsions as potential bioadhesive carriers for ophthalmic delivery of palmatine, Journal of Microencapsulation, vol.19, issue.8, pp.718-724, 2016.
DOI : 10.2174/138920021603150812124221

T. Higuchi, Ocular Insert. U.S. Patent, vol.3630, 1971.

A. Kumari, P. Sharma, V. Garg, and G. Garg, Ocular inserts - Advancement in therapy of eye diseases, Journal of Advanced Pharmaceutical Technology & Research, vol.1, issue.3, p.291, 2010.
DOI : 10.4103/0110-5558.72419

T. Ara, S. Sharma, S. A. Bhat, A. Bhandari, A. S. Deva et al., Preparation and evaluation of ocular inserts of diclofenac sodium for controlled drug delivery, Int. J. Sci. Res. Publ, vol.5, pp.93-99, 2015.

M. Shukr, Formulation, in vitro and in vivo evaluation of lidocaine HCl ocular inserts for topical ocular anesthesia, Arch. Pharm. Res, vol.2014, issue.37, pp.882-889

S. Kumar, K. P. Bhowmik, D. Harish, G. Duraivel, S. Pragathi-kumar et al., Ocular inserts: A novel controlled drug delivery system. The Pharm, pp.1-16, 2012.

F. Gurtler and R. Gurny, Patent Literature Review of Ophthalmic Inserts, Drug Development and Industrial Pharmacy, vol.6, issue.1, pp.1-18, 1995.
DOI : 10.3109/02713688509017674

P. Baranowski, B. Karolewicz, M. Gajda, and J. Pluta, Ophthalmic Drug Dosage Forms: Characterisation and Research Methods, The Scientific World Journal, vol.45, issue.6, pp.1-14, 2014.
DOI : 10.1016/S0039-6257(01)00211-9
URL : http://doi.org/10.1155/2014/861904

A. Guzman-aranguez, B. Colligris, and J. Pintor, Contact Lenses: Promising Devices for Ocular Drug Delivery, Journal of Ocular Pharmacology and Therapeutics, vol.29, issue.2, pp.189-199
DOI : 10.1089/jop.2012.0212

F. Stapleton, S. Stretton, E. Papas, C. Skotnitsky, and D. F. Sweeney, Silicone Hydrogel Contact Lenses and the Ocular Surface, The Ocular Surface, vol.4, issue.1, pp.24-43, 2006.
DOI : 10.1016/S1542-0124(12)70262-8

E. Van-der-worp, D. Bornman, D. L. Ferreira, M. Faria-ribeiro, N. Garcia-porta et al., Modern scleral contact lenses: A review, Contact Lens and Anterior Eye, vol.37, issue.4, pp.240-250, 2014.
DOI : 10.1016/j.clae.2014.02.002

J. S. Harthan, Therapeutic use of mini-scleral lenses in a patient with Graves??? ophthalmopathy, Journal of Optometry, vol.7, issue.1, pp.62-66
DOI : 10.1016/j.optom.2012.11.002

V. M. Rathi, S. Dumpati, P. S. Mandathara, M. M. Taneja, and V. S. Sangwan, Scleral contact lenses in the management of pellucid marginal degeneration, Contact Lens and Anterior Eye, vol.39, issue.3, pp.217-220, 2016.
DOI : 10.1016/j.clae.2015.11.005

B. Severinsky, S. Behrman, J. Frucht-pery, and A. Solomon, Scleral contact lenses for visual rehabilitation after penetrating keratoplasty: Long term outcomes, Contact Lens and Anterior Eye, vol.37, issue.3, pp.196-202, 2014.
DOI : 10.1016/j.clae.2013.11.001

T. Romero-rangel, P. Stavrou, J. Cotter, P. Rosenthal, S. Baltatzis et al., Gas-permeable scleral contact lens therapy in ocular surface disease, American Journal of Ophthalmology, vol.130, issue.1, pp.25-32, 2000.
DOI : 10.1016/S0002-9394(00)00378-0

E. G. Kramer and E. L. Boshnick, Scleral lenses in the treatment of post-LASIK ectasia and superficial neovascularization of intrastromal corneal ring segments, Contact Lens and Anterior Eye, vol.38, issue.4, pp.298-303, 2015.
DOI : 10.1016/j.clae.2015.02.003

Y. Inamoto, Y. Sun, M. E. Flowers, P. A. Carpenter, P. J. Martin et al., Bandage Soft Contact Lenses for Ocular Graft-versus-Host Disease, Biology of Blood and Marrow Transplantation, vol.21, issue.11, pp.2002-2007, 2015.
DOI : 10.1016/j.bbmt.2015.07.013
URL : https://doi.org/10.1016/j.bbmt.2015.07.013

R. J. Glisoni, M. J. García-fernández, M. Pino, G. Gutkind, and A. G. Moglioni, C

A. Concheiro, Sosnik, A. ?-Cyclodextrin hydrogels for the ocular release of antibacterial thiosemicarbazones, Carbohydr. Polym, vol.2013, issue.93, pp.449-457

M. Teixeira, M. J. Alonso, M. M. Pinto, and C. M. Barbosa, Development and characterization of PLGA nanospheres and nanocapsules containing xanthone and 3-methoxyxanthone, European Journal of Pharmaceutics and Biopharmaceutics, vol.59, issue.3, pp.491-500, 2005.
DOI : 10.1016/j.ejpb.2004.09.002

Y. Diebold and M. Calonge, Applications of nanoparticles in ophthalmology, Progress in Retinal and Eye Research, vol.29, issue.6, pp.596-609
DOI : 10.1016/j.preteyeres.2010.08.002

Q. Xu, S. P. Kambhampati, and R. M. Kannan, Nanotechnology approaches for ocular drug delivery, Middle East Afr. J. Ophthalmol, vol.20, pp.26-37, 2013.

V. J. Mohanraj and Y. Chen, Nanoparticles?A review. Trop, J. Pharm. Res, vol.5, pp.561-573, 2006.

L. Yildirimer, N. T. Thanh, M. Loizidou, and A. M. Seifalian, Toxicology and clinical potential of nanoparticles, Nano Today, vol.6, issue.6, pp.585-607, 2011.
DOI : 10.1016/j.nantod.2011.10.001

L. Duxfield, R. Sultana, R. Wang, V. Englebretsen, S. Deo et al., Development of gatifloxacin-loaded cationic polymeric nanoparticles for ocular drug delivery, Pharmaceutical Development and Technology, vol.6, issue.2, pp.172-179, 2016.
DOI : 10.1128/AAC.00722-08

E. A. Mun, P. W. Morrison, A. C. Williams, and V. V. Khutoryanskiy, On the Barrier Properties of the Cornea: A Microscopy Study of the Penetration of Fluorescently Labeled Nanoparticles, Polymers, and Sodium Fluorescein, Molecular Pharmaceutics, vol.11, issue.10, pp.3556-3564, 2014.
DOI : 10.1021/mp500332m

A. D. Bangham, M. M. Standish, and J. C. Watkins, Diffusion of univalent ions across the lamellae of swollen phospholipids, Journal of Molecular Biology, vol.13, issue.1, pp.238-252, 1965.
DOI : 10.1016/S0022-2836(65)80093-6

, Pharmaceutics, vol.10, pp.10-27, 2018.

D. Meisner and M. Mezei, Liposome ocular delivery systems, Advanced Drug Delivery Reviews, vol.16, issue.1, pp.75-93, 1995.
DOI : 10.1016/0169-409X(95)00016-Z

G. P. Mishra, M. Bagui, V. Tamboli, and A. K. Mitra, Recent Applications of Liposomes in Ophthalmic Drug Delivery, Journal of Drug Delivery, vol.32, issue.13, p.863734, 2011.
DOI : 10.1016/j.ejpb.2009.03.010

R. M. Hathout, S. Mansour, N. D. Mortada, and A. S. Guinedi, Liposomes as an ocular delivery system for acetazolamide: In vitro and in vivo studies, AAPS PharmSciTech, vol.8, issue.1, 2007.
DOI : 10.1208/pt0801001

N. Khanam, M. I. Alam, A. K. Sachan, and R. Sharma, Recent trends in drug delivery by niosomes: A review, pp.115-122

T. T. Pham, C. Jaafar-maalej, C. Charcosset, and H. Fessi, Liposome and niosome preparation using a membrane contactor for scale-up, Colloids and Surfaces B: Biointerfaces, vol.94, pp.15-21, 2012.
DOI : 10.1016/j.colsurfb.2011.12.036
URL : https://hal.archives-ouvertes.fr/hal-02013679

M. Kalomiraki, K. Thermos, and N. A. Chaniotakis, Dendrimers as tunable vectors of drug delivery systems and biomedical and ocular applications, Int. J. Nanomedicine, vol.11, pp.1-12, 2015.

Y. Burçin, S. Bozdag-pehlivan, and S. Ünlü, Dendrimeric systems and their applications in ocular drug delivery. Sci, 2013.

T. F. Vandamme and L. Brobeck, Poly(amidoamine) dendrimers as ophthalmic vehicles for ocular delivery of pilocarpine nitrate and tropicamide, Journal of Controlled Release, vol.102, issue.1, pp.23-38, 2005.
DOI : 10.1016/j.jconrel.2004.09.015
URL : https://hal.archives-ouvertes.fr/hal-00129825

A. Fleming, On the Antibacterial Action of Cultures of a Penicillium, with Special Reference to Their Use in the Isolation of B. influenzae, Clinical Infectious Diseases, vol.2, issue.1, pp.226-236, 1929.
DOI : 10.1093/clinids/2.1.129

C. O. Gualerzi, L. Brandi, A. Fabbretti, and C. L. Pon, Antibiotics: Targets, Mechanisms and Resistance, 2013.
DOI : 10.1002/9783527659685

A. Kapoor, R. Malhotra, V. Grover, and D. Grover, Systemic antibiotic therapy in periodontics, Dental Research Journal, vol.9, issue.5, pp.505-515
DOI : 10.4103/1735-3327.104866

P. Cornut and C. Chiquet, Injections intravitr??ennes d???antibiotiques et endophtalmies, Journal Fran??ais d'Ophtalmologie, vol.31, issue.8, pp.815-823, 2008.
DOI : 10.1016/S0181-5512(08)74405-X

M. Barza, Factors affecting the intraocular penetration of antibiotics. The influence of route, inflammation, animal species and tissue pigmentation. Scand, J. Infect. Dis, pp.151-159, 1978.

R. W. Snyder and D. B. Glasser, Antibiotic therapy for ocular infection, West. J. Med, vol.161, pp.579-584, 1994.

S. Shimpi, B. Chauhan, and P. Shimpi, Cyclodextrins: application in different routes of drug administration, Acta Pharm. Zagreb Croat, vol.55, pp.139-156, 2005.

G. Tiwari, R. Tiwari, and A. K. Rai, Cyclodextrins in delivery systems: Applications, Journal of Pharmacy And Bioallied Sciences, vol.2, issue.2, 2010.
DOI : 10.4103/0975-7406.67003

S. P. Agarwal, Development of an ophthalmic formulation containing ciprofloxacin-hydroxypropyl-b-cyclodextrin complex, Boll. Chim. Farm, vol.142, pp.214-219, 2003.

A. Bozkir, Z. F. Denli, and B. Basaran, Effect of hydroxypropyl-beta-cyclodextrin on the solubility, stability and in-vitro release of ciprofloxacin for ocular drug delivery, Acta Pol. Pharm, vol.69, pp.719-724, 2012.

T. R. Thatiparti and H. A. Von-recum, Cyclodextrin Complexation for Affinity-Based Antibiotic Delivery, Macromolecular Bioscience, vol.100, issue.1, pp.82-90, 2010.
DOI : 10.1111/j.2042-7158.1994.tb03711.x

K. W. Pullum, The unique role of scleral lenses in contact lens practice, Contact Lens and Anterior Eye, vol.22, pp.26-34, 1999.
DOI : 10.1016/S1367-0484(99)80040-X

B. Tougeron-brousseau, A. Delcampe, J. Gueudry, L. Vera, S. Doan et al., Vision-Related Function After Scleral Lens Fitting in Ocular Complications of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis, American Journal of Ophthalmology, vol.148, issue.6, pp.852-859, 2009.
DOI : 10.1016/j.ajo.2009.07.006

R. Laballe, J. Vigne, E. Denion, F. Lemaitre, D. Goux et al., Preclinical assessment of scleral lens as a reservoir-based ocular therapeutic system, Contact Lens and Anterior Eye, vol.39, issue.5, pp.394-396, 2016.
DOI : 10.1016/j.clae.2016.04.008

X. Hu, H. Tan, and L. Hao, Functional hydrogel contact lens for drug delivery in the application of oculopathy therapy, Journal of the Mechanical Behavior of Biomedical Materials, vol.64, pp.43-52, 2016.
DOI : 10.1016/j.jmbbm.2016.07.005

X. Tian, M. Iwatsu, K. Sado, and A. Kanai, Studies on the uptake and release of fluoroquinolones by disposable contact lenses, CLAO J. Off. Publ. Contact Lens Assoc. Ophthalmol. Inc, vol.27, pp.216-220, 2001.

E. M. Hehl, R. Beck, K. Luthard, R. Guthoff, and B. Drewelow, Improved penetration of aminoglycosides and fluoroquinolones into the aqueous humour of patients by means of Acuvue contact lenses, European Journal of Clinical Pharmacology, vol.55, issue.4, pp.317-323, 1999.
DOI : 10.1007/s002280050635

Y. Yokozaki, J. Sakabe, and Y. Shimoyama, Enhanced impregnation of hydrogel contact lenses with salicylic acid by addition of water in supercritical carbon dioxide, Chemical Engineering Research and Design, vol.104, pp.203-207, 2015.
DOI : 10.1016/j.cherd.2015.08.007

V. P. Costa, M. E. Braga, J. P. Guerra, A. R. Duarte, C. M. Duarte et al., Development of therapeutic contact lenses using a supercritical solvent impregnation method, The Journal of Supercritical Fluids, vol.52, issue.3, pp.306-316, 2010.
DOI : 10.1016/j.supflu.2010.02.001

C. Alvarez-lorenzo, F. Yañez, and A. Concheiro, Ocular drug delivery from molecularly-imprinted contact lenses, Journal of Drug Delivery Science and Technology, vol.20, issue.4, pp.237-248, 2010.
DOI : 10.1016/S1773-2247(10)50041-8

C. Alvarez-lorenzo, F. Yañez, R. Barreiro-iglesias, and A. Concheiro, Imprinted soft contact lenses as norfloxacin delivery systems, Journal of Controlled Release, vol.113, issue.3, pp.236-244, 2006.
DOI : 10.1016/j.jconrel.2006.05.003

N. Malakooti, C. Alexander, and C. Alvarez-lorenzo, Imprinted Contact Lenses for Sustained Release of Polymyxin B and Related Antimicrobial Peptides, Journal of Pharmaceutical Sciences, vol.104, issue.10, pp.3386-3394
DOI : 10.1002/jps.24537
URL : http://eprints.nottingham.ac.uk/39083/1/Malakooti%20et%20al%20JPS%202015%20AAM.pdf

H. Ozawa, S. Hosaka, T. Kunitomo, and H. Tanzawa, Ocular inserts for controlled release of antibiotics, Biomaterials, vol.4, issue.3, pp.170-174, 1983.
DOI : 10.1016/0142-9612(83)90005-4

S. Hosaka, H. Ozawa, H. Tanzawa, T. Kinitomo, and R. L. Nichols, In vivo evaluation of ocular inserts of hydrogel impregnated with antibiotics fop trachoma therapy, Biomaterials, vol.4, issue.4, pp.243-248, 1983.
DOI : 10.1016/0142-9612(83)90022-4

P. I. Punch, N. D. Costa, M. E. Edwards, and G. Wilcox, The release of insoluble antibiotics from collagen ocular inserts in vitro and their insertion into the conjunctival sac of cattle, Journal of Veterinary Pharmacology and Therapeutics, vol.62, issue.4, pp.37-42, 1987.
DOI : 10.1111/j.1751-0813.1982.tb02700.x

V. Baeyens, V. Kaltsatos, B. Boisramé, E. Varesio, J. Veuthey et al., Optimized release of dexamethasone and gentamicin from a soluble ocular insert for the treatment of external ophthalmic infections, Journal of Controlled Release, vol.52, issue.1-2, pp.215-220, 1998.
DOI : 10.1016/S0168-3659(97)00212-5

D. Colo, G. Burgalassi, S. Chetoni, P. Fiaschi, M. P. Zambito et al., Gel-forming erodible inserts for ocular controlled delivery of ofloxacin, International Journal of Pharmaceutics, vol.215, issue.1-2, pp.101-111, 2001.
DOI : 10.1016/S0378-5173(00)00671-2

D. Colo, G. Burgalassi, S. Chetoni, P. Fiaschi, M. P. Zambito et al., Relevance of polymer molecular weight to the in vitro

, Int. J. Pharm, vol.220, pp.169-177, 2001.

D. Colo, G. Zambito, Y. Burgalassi, S. Serafini, A. Saettone et al., Effect of chitosan on in vitro release and ocular delivery of ofloxacin from erodible inserts based on poly(ethylene oxide). Int Novel nanostructured lipid carrier-based inserts for controlled ocular drug delivery: Evaluation of corneal bioavailability and treatment efficacy in bacterial keratitis, J. Pharm. Expert Opin. Drug Deliv, vol.248, issue.12, pp.115-122, 2002.

Y. Sultana, M. Aqil, and A. Ali, Ocular inserts for controlled delivery of pefloxacin mesylate: Preparation and evaluation, Acta Pharm. Zagreb Croat, vol.55, pp.305-314, 2005.

A. S. Mundada and B. K. Shrikhande, Design and Evaluation of Soluble Ocular Drug Insert for Controlled Release of Ciprofloxacin Hydrochloride, Drug Development and Industrial Pharmacy, vol.29, issue.1, pp.443-448, 2006.
DOI : 10.1007/978-1-4757-4175-9_16

A. S. Mundada and B. K. Shrikhande, Formulation and Evaluation of Ciprofloxacin Hydrochloride Soluble Ocular Drug Insert, Current Eye Research, vol.66, issue.5-6, pp.469-475, 2008.
DOI : 10.1081/DDC-100108373

P. K. Pawar, R. Katara, and D. K. Majumdar, Design and evaluation of moxifloxacin hydrochloride ocular inserts, Acta Pharmaceutica, vol.48, issue.1, pp.93-104
DOI : 10.1016/S0928-0987(01)00095-1
URL : http://www.degruyter.com/downloadpdf/j/acph.2012.62.issue-1/v10007-012-0002-5/v10007-012-0002-5.xml

R. Thakur, G. Swami, and M. Rahman, Development and Optimization of Controlled Release Bioerodable Anti Infective Ophthalmic Insert, Current Drug Delivery, vol.11, issue.1, pp.2-10
DOI : 10.2174/15672018113106660060

J. Wang, X. Li, L. Xiong, and N. Sun, Different concentrations of clarithromycin ophthalmic gel for rabbits corneal ulcers induced by Staphylococcus aureus, Yan Ke Xue Bao, vol.24, pp.18-22, 2008.

Z. Liu, J. Li, S. Nie, H. Liu, P. Ding et al., Study of an alginate/HPMC-based in situ gelling ophthalmic delivery system for gatifloxacin, International Journal of Pharmaceutics, vol.315, issue.1-2, pp.12-17, 2006.
DOI : 10.1016/j.ijpharm.2006.01.029

R. S. Al-kassas and M. M. El-khatib, Ophthalmic controlled release in situ gelling systems for ciprofloxacin based on polymeric carriers. Drug Deliv, pp.145-152, 2009.
DOI : 10.1080/10717540802689008
URL : http://www.tandfonline.com/doi/pdf/10.1080/10717540802689008?needAccess=true

M. Mansour, S. Mansour, and N. D. Mortada, Ocular Poloxamer-Based Ciprofloxacin Hydrochloride In Situ Forming Gels, Drug Development and Industrial Pharmacy, vol.94, issue.7, pp.744-752, 2008.
DOI : 10.1016/S0378-5173(01)00809-2

B. K. Nanjwade, R. V. Deshmukh, K. R. Gaikwad, K. A. Parikh, and F. Manvi, Formulation and evaluation of micro hydrogel of Moxifloxacin hydrochloride, European Journal of Drug Metabolism and Pharmacokinetics, vol.73, issue.2, pp.117-123
DOI : 10.1016/S0168-3659(01)00279-6

N. Khan, M. Aqil, S. S. Imam, and A. Ali, characterization, Pharmaceutical Development and Technology, vol.315, issue.6, pp.662-669, 2015.
DOI : 10.1016/j.ijpharm.2006.01.029
URL : https://hal.archives-ouvertes.fr/hal-01709045

Y. Sultana, M. Aqil, A. Ali, and S. Zafar, Evaluation of Carbopol-Methyl Cellulose Based Sustained-Release Ocular Delivery System for Pefloxacin Mesylate Using Rabbit Eye Model, Pharmaceutical Development and Technology, vol.57, issue.4, pp.313-319, 2006.
DOI : 10.1002/jps.2600570206

Z. Liu, X. Yang, X. Li, W. Pan, and J. Li, Study on the Ocular Pharmacokinetics of Ion-Activated In Situ Gelling Ophthalmic Delivery System for Gatifloxacin by Microdialysis, Drug Development and Industrial Pharmacy, vol.253, issue.2, pp.1327-1331, 2007.
DOI : 10.1016/0006-8993(94)91956-9

H. M. El-laithy, D. I. Nesseem, A. A. El-adly, and M. Shoukry, Moxifloxacin-gelrite In Situ ophthalmic gelling system against photodynamic therapy for treatment of bacterial corneal inflammation, Archives of Pharmacal Research, vol.9, issue.Suppl1, pp.1663-1678, 2011.
DOI : 10.1186/1471-2180-9-27

J. Ameeduzzafar-;-ali, M. Fazil, M. Qumbar, N. Khan, and A. Ali, Colloidal drug delivery system: Amplify the ocular delivery, Drug Deliv, vol.23, pp.700-716, 2014.

H. O. Ammar, H. A. Salama, M. Ghorab, and A. A. Mahmoud, Nanoemulsion as a Potential Ophthalmic Delivery System for Dorzolamide Hydrochloride, AAPS PharmSciTech, vol.10, issue.3, pp.808-817, 2009.
DOI : 10.1208/s12249-009-9268-4
URL : http://europepmc.org/articles/pmc2802135?pdf=render

F. Lv, L. Zheng, and C. Tung, Phase behavior of the microemulsions and the stability of the chloramphenicol in the microemulsion-based ocular drug delivery system, International Journal of Pharmaceutics, vol.301, issue.1-2, pp.237-246, 2005.
DOI : 10.1016/j.ijpharm.2005.06.006

S. K. Bharti and K. Kesavan, Phase-transition W/O Microemulsions for Ocular Delivery: Evaluation of Antibacterial Activity in the Treatment of Bacterial Keratitis, Ocular Immunology and Inflammation, vol.81, issue.4, pp.1-12
DOI : 10.1023/A:1022283423116

N. Üstündag-okur, E. H. Gökçe, S. Grilmez, Ö. Özer, and G. Ertan, Novel Ofloxacin-Loaded Microemulsion Formulations for Ocular Delivery, Journal of Ocular Pharmacology and Therapeutics, vol.30, issue.4, pp.319-332, 2014.
DOI : 10.1089/jop.2013.0114

M. A. Kalam, A. Alshamsan, I. A. Aljuffali, A. K. Mishra, and Y. Sultana, Delivery of gatifloxacin using microemulsion as vehicle: formulation, evaluation, transcorneal permeation and aqueous humor drug determination, Drug Delivery, vol.55, pp.896-907, 2016.
DOI : 10.1016/0169-409X(95)00017-2
URL : http://www.tandfonline.com/doi/pdf/10.3109/10717544.2014.920432?needAccess=true

X. Li, R. H. Müller, C. M. Keck, and N. A. Bou-chacra, Mucoadhesive dexamethasone acetate-polymyxin B sulfate cationic ocular nanoemulsion?novel combinatorial formulation concept, Int. J. Pharm. Sci, vol.71, pp.327-333, 2016.

H. Almeida, M. H. Amaral, P. Lobao, C. Frigerio, and J. M. Sousa-lobo, Nanoparticles in Ocular Drug Delivery Systems for Topical Administration: Promises and Challenges, Current Pharmaceutical Design, vol.21, issue.36, pp.5212-5224, 2015.
DOI : 10.2174/1381612821666150923095155

H. Zhou, J. Hao, S. Wang, Y. Zheng, and W. Zhang, Nanoparticles in the ocular drug delivery, Int. J. Ophthalmol. 2013, vol.6, pp.390-396

S. Das, P. K. Suresh, and R. Desmukh, Design of Eudragit RL 100 nanoparticles by nanoprecipitation method for ocular drug delivery, Nanomedicine: Nanotechnology, Biology and Medicine, vol.6, issue.2, pp.318-323, 2010.
DOI : 10.1016/j.nano.2009.09.002

B. Mandal, K. S. Alexander, and A. Riga, Sulfacetamide loaded Eudragit ® RL100 nanosuspension with potential for ocular delivery, J. Pharm. Pharm. Sci. Publ. Can. Soc. Pharm. Sci. Soc. Can. Sci. Pharm, vol.13, pp.510-523, 2010.

H. K. Ibrahim, I. S. El-leithy, and A. A. Makky, Mucoadhesive Nanoparticles as Carrier Systems for Prolonged Ocular Delivery of Gatifloxacin/Prednisolone Bitherapy, Molecular Pharmaceutics, vol.7, issue.2, pp.576-585, 2010.
DOI : 10.1021/mp900279c

M. Y. Lee, S. Bourgeois, E. Almouazen, J. Pelletier, F. Renaud et al., Microencapsulation of rifampicin for the prevention of endophthalmitis: In vitro release studies and antibacterial assessment, International Journal of Pharmaceutics, vol.505, issue.1-2, pp.262-270, 2016.
DOI : 10.1016/j.ijpharm.2016.03.026
URL : https://hal.archives-ouvertes.fr/hal-01814080

W. Hachicha, L. Kodjikian, and H. Fessi, Preparation of vancomycin microparticles: Importance of preparation parameters, International Journal of Pharmaceutics, vol.324, issue.2, pp.176-184, 2006.
DOI : 10.1016/j.ijpharm.2006.06.005

H. Gupta, M. Aqil, R. K. Khar, A. Ali, A. Bhatnagar et al., Sparfloxacin-loaded PLGA nanoparticles for sustained ocular drug delivery, Nanomedicine: Nanotechnology, Biology and Medicine, vol.6, issue.2, pp.324-333, 2010.
DOI : 10.1016/j.nano.2009.10.004

H. Gupta, M. Aqil, R. K. Khar, A. Ali, A. Bhatnagar et al., Biodegradable levofloxacin nanoparticles for sustained ocular drug delivery, Journal of Drug Targeting, vol.34, issue.6, pp.409-417, 2011.
DOI : 10.1002/jps.21383

G. Mohammadi, A. Nokhodchi, M. Barzegar-jalali, F. Lotfipour, K. Adibkia et al., Physicochemical and anti-bacterial performance characterization of clarithromycin nanoparticles as colloidal drug delivery system, Colloids and Surfaces B: Biointerfaces, vol.88, issue.1, pp.39-44, 2011.
DOI : 10.1016/j.colsurfb.2011.05.050

V. Pokharkar, V. Patil, and L. Mandpe, Engineering of polymer-surfactant nanoparticles of doxycycline hydrochloride for ocular drug delivery. Drug Deliv, pp.955-968, 2015.

S. K. Motwani, S. Chopra, S. Talegaonkar, K. Kohli, F. J. Ahmad et al., Chitosan???sodium alginate nanoparticles as submicroscopic reservoirs for ocular delivery: Formulation, optimisation and in vitro characterisation, European Journal of Pharmaceutics and Biopharmaceutics, vol.68, pp.513-525, 2008.
DOI : 10.1016/j.ejpb.2007.09.009

N. C. Silva, S. Silva, B. Sarmento, and M. Pintado, Chitosan nanoparticles for daptomycin delivery in ocular treatment of bacterial endophthalmitis. Drug Deliv, pp.885-893, 2015.

J. R. Costa, N. C. Silva, B. Sarmento, and M. Pintado, Potential chitosan-coated alginate nanoparticles for ocular delivery of daptomycin, European Journal of Clinical Microbiology & Infectious Diseases, vol.224, issue.6, pp.1255-1262, 2015.
DOI : 10.1016/S0378-5173(01)00760-8

E. Sánchez-lópez, M. Espina, S. Doktorovova, E. B. Souto, and M. L. García, Lipid nanoparticles (SLN, NLC): Overcoming the anatomical and physiological barriers of the eye ??? Part II - Ocular drug-loaded lipid nanoparticles, European Journal of Pharmaceutics and Biopharmaceutics, vol.110, pp.58-69, 2017.
DOI : 10.1016/j.ejpb.2016.10.013

M. A. Kalam, Y. Sultana, A. Ali, M. Aqil, A. K. Mishra et al., Preparation, characterization, and evaluation of gatifloxacin loaded solid lipid nanoparticles as colloidal ocular drug delivery system, Journal of Drug Targeting, vol.41, issue.3, pp.191-204, 2010.
DOI : 10.1016/j.ijpharm.2005.05.036

A. Kalam, M. Sultana, Y. Ali, A. Aqil, M. Mishra et al., A.; Alshamsan, A. Part I: Development and optimization of solid-lipid nanoparticles using Box-Behnken statistical design for ocular delivery of gatifloxacin, J. Biomed. Mater. Res. A, vol.101, pp.1813-1827, 2013.
URL : https://hal.archives-ouvertes.fr/hal-00085569

A. Kalam, M. Sultana, Y. Ali, A. Aqil, M. Mishra et al., Part II: Enhancement of transcorneal delivery of gatifloxacin by solid lipid nanoparticles in comparison to commercial aqueous eye drops, J. Biomed. Mater. Res. A, vol.101, pp.1828-1836, 2013.

M. S. Baig, A. Ahad, M. Aslam, S. S. Imam, M. Aqil et al., Application of Box???Behnken design for preparation of levofloxacin-loaded stearic acid solid lipid nanoparticles for ocular delivery: Optimization, in vitro release, ocular tolerance, and antibacterial activity, International Journal of Biological Macromolecules, vol.85, pp.258-270, 2016.
DOI : 10.1016/j.ijbiomac.2015.12.077

C. Yousry, R. H. Fahmy, T. Essam, H. M. El-laithy, and S. A. Elkheshen, Nanoparticles as tool for enhanced ophthalmic delivery of vancomycin: a multidistrict-based microbiological study, solid lipid nanoparticles formulation and evaluation, Drug Development and Industrial Pharmacy, vol.2, issue.11, pp.1752-1762, 2016.
DOI : 10.1016/j.nano.2009.10.004

P. Chetoni, S. Burgalassi, D. Monti, S. Tampucci, V. Tullio et al., Solid lipid nanoparticles as promising tool for intraocular tobramycin delivery: Pharmacokinetic studies on rabbits, European Journal of Pharmaceutics and Biopharmaceutics, vol.109, pp.214-223, 2016.
DOI : 10.1016/j.ejpb.2016.10.006

M. M. Mehanna, H. A. Elmaradny, and M. W. Samaha, Ciprofloxacin Liposomes as Vesicular Reservoirs for Ocular Delivery: Formulation, Optimization, and In Vitro Characterization, Drug Development and Industrial Pharmacy, vol.41, issue.5, pp.583-593, 2009.
DOI : 10.1016/0169-409X(95)00017-2

P. Chetoni, D. Monti, S. Tampucci, B. Matteoli, L. Ceccherini-nelli et al., Liposomes as a potential ocular delivery system of distamycin A. Int, J. Pharm, vol.492, pp.120-126, 2015.

M. M. Mehanna, H. A. Elmaradny, and M. W. Samaha, Mucoadhesive liposomes as ocular delivery system: physical, microbiological, and in vivo assessment, Drug Development and Industrial Pharmacy, vol.75, issue.1, pp.108-118, 2010.
DOI : 10.1081/DDC-120016729

G. Abdelbary, Ocular ciprofloxacin hydrochloride mucoadhesive chitosan-coated liposomes, Pharmaceutical Development and Technology, vol.86, issue.2, pp.44-56, 2011.
DOI : 10.1016/S0168-3659(02)00411-X

L. Budai, M. Hajdú, M. Budai, P. Gróf, S. Béni et al., Gels and liposomes in optimized ocular drug delivery: Studies on ciprofloxacin formulations, International Journal of Pharmaceutics, vol.343, issue.1-2, pp.34-40, 2007.
DOI : 10.1016/j.ijpharm.2007.04.013

, Pharmaceutics, vol.10, pp.10-31, 2018.

K. M. Hosny, Preparation and Evaluation of Thermosensitive Liposomal Hydrogel for Enhanced Transcorneal Permeation of Ofloxacin, AAPS PharmSciTech, vol.10, issue.4, pp.1336-1342, 2009.
DOI : 10.1208/s12249-009-9335-x

K. M. Hosny, Ciprofloxacin as Ocular Liposomal Hydrogel, AAPS PharmSciTech, vol.11, issue.1, pp.241-246, 2010.
DOI : 10.1208/s12249-009-9373-4

K. M. Hosny, Optimization of gatifloxacin liposomal hydrogel for enhanced transcorneal permeation, Journal of Liposome Research, vol.22, issue.1, pp.31-37, 2010.
DOI : 10.1023/A:1006137100444

S. Zeng, C. Hu, H. Wei, Y. Lu, Y. Zhang et al., Intravitreal Pharmacokinetics of Liposome-encapsulated Amikacin in a Rabbit Model, Ophthalmology, vol.100, issue.11, pp.1640-1644, 1993.
DOI : 10.1016/S0161-6420(93)31423-5

B. Wiechens, R. Krausse, J. B. Grammer, D. Neumann, U. Pleyer et al., Glask??rper-Clearance von liposomeninkorporiertem Ciprofloxacin nach intravitrealer Injektion, Klinische Monatsbl??tter f??r Augenheilkunde, vol.213, issue.11, pp.284-292, 1998.
DOI : 10.1055/s-2008-1034989

J. M. Kaiser, H. Imai, J. K. Haakenson, R. M. Brucklacher, T. E. Fox et al., Freeman, W.M

, Nanomedicine Nanotechnol. Biol. Med, vol.2013, issue.9, pp.130-140

A. S. Guinedi, N. D. Mortada, S. Mansour, and R. M. Hathout, Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide, International Journal of Pharmaceutics, vol.306, issue.1-2, pp.71-82, 2005.
DOI : 10.1016/j.ijpharm.2005.09.023

D. Aggarwal, D. Pal, A. K. Mitra, and I. P. Kaur, Study of the extent of ocular absorption of acetazolamide from a developed niosomal formulation, by microdialysis sampling of aqueous humor, International Journal of Pharmaceutics, vol.338, issue.1-2, pp.21-26, 2007.
DOI : 10.1016/j.ijpharm.2007.01.019

G. Abdelbary and N. El-gendy, Niosome-Encapsulated Gentamicin for Ophthalmic Controlled Delivery, AAPS PharmSciTech, vol.9, issue.3, pp.740-747, 2008.
DOI : 10.1208/s12249-008-9105-1

V. Akbari, D. Abedi, A. Pardakhty, and H. Sadeghi-aliabadi, Release studies on ciprofloxacin loaded non-ionic surfactant vesicles, Avicenna J. Med. Biotechnol, vol.7, pp.69-75, 2015.